Modulation of collagen type I, fibronectin and dermal fibroblast function and activity, in systemic sclerosis by the antioxidant epigallocatechin-3-gallate.
暂无分享,去创建一个
R. Bruckdorfer | D. Abraham | C. Denton | X. Shi-wen | A. Dooley | T. Tranah | N. Aden | N. Desai | Shi-wen Xu
[1] A. Desmoulière,et al. The Myofibroblast: one function, multiple origins , 2010 .
[2] Hyunggee Kim,et al. Green Tea Polyphenol Epigallocatechin-3-Gallate Suppresses Collagen Production and Proliferation in Keloid Fibroblasts via Inhibition of the STAT 3-Signaling Pathway , 2010 .
[3] Y. Osawa,et al. (-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R. , 2009, Chemico-biological interactions.
[4] F. Martinez,et al. NADPH Oxidase-4 Mediates Myofibroblast Activation and Fibrogenic Responses to Lung Injury , 2009, Nature Medicine.
[5] H. Mukhtar,et al. Multitargeted therapy of cancer by green tea polyphenols. , 2008, Cancer letters.
[6] Hyunggee Kim,et al. Green tea polyphenol epigallocatechin-3-gallate suppresses collagen production and proliferation in keloid fibroblasts via inhibition of the STAT3-signaling pathway. , 2008, The Journal of investigative dermatology.
[7] Oliver Distler,et al. Rho-associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblasts. , 2008, Arthritis and rheumatism.
[8] S. Svegliati,et al. Oxidative stress and the pathogenesis of scleroderma: the Murrell’s hypothesis revisited , 2008, Seminars in Immunopathology.
[9] I. Booth,et al. Acid survival of Escherichia coli; how dead is dead? , 2008, Proceedings of the Nutrition Society.
[10] K. Bruckdorfer. Antioxidants and CVD , 2008, Proceedings of the Nutrition Society.
[11] S. Low,et al. The nitration of platelet vasodilator stimulated phosphoprotein following exposure to low concentrations of hydrogen peroxide , 2008, Platelets.
[12] S. Low,et al. Nitric oxide synthase expression and activity in the tight-skin mouse model of fibrosis. , 2007, Rheumatology.
[13] G. Galbraith. A Polymorphism in the CTGF Promoter Region Associated with Systemic Sclerosis , 2008 .
[14] H. Nishikawa,et al. Inhibition of NADPH oxidase subunits translocation by tea catechin EGCG in mast cell. , 2007, Biochemical and biophysical research communications.
[15] D. Abraham,et al. Effect of nitric oxide and peroxynitrite on type I collagen synthesis in normal and scleroderma dermal fibroblasts. , 2007, Free radical biology & medicine.
[16] Vineeth Rajkumar,et al. New developments in fibroblast and myofibroblast biology: Implications for fibrosis and scleroderma , 2007, Current rheumatology reports.
[17] Yan-Qing Li,et al. Effects of epigallocatechin gallate on diethyldithiocarbamate-induced pancreatic fibrosis in rats. , 2007, Biological & pharmaceutical bulletin.
[18] G. Tipoe,et al. Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection. , 2007, Cardiovascular & hematological disorders drug targets.
[19] K. Stangl,et al. Molecular targets of tea polyphenols in the cardiovascular system. , 2007, Cardiovascular research.
[20] B. Thiers. Green tea and skin cancer: photoimmunology, angiogenesis and DNA repair , 2007 .
[21] A. Gabrielli,et al. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. , 2006, The New England journal of medicine.
[22] Gang Lu,et al. Molecular targets for the cancer preventive activity of tea polyphenols , 2006, Molecular carcinogenesis.
[23] C. Black,et al. Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine. , 2006, Rheumatology.
[24] De-Pei Liu,et al. Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways. , 2006, Free radical biology & medicine.
[25] Yunliang Chen,et al. Contribution of activin receptor-like kinase 5 (transforming growth factor beta receptor type I) signaling to the fibrotic phenotype of scleroderma fibroblasts. , 2006, Arthritis and rheumatism.
[26] D. Abraham,et al. Mechanisms and consequences of fibrosis in systemic sclerosis , 2006, Nature Clinical Practice Rheumatology.
[27] M. Taguchi,et al. Green tea polyphenol (–)‐epigallocatechin‐3‐gallate inhibits ethanol‐induced activation of pancreatic stellate cells , 2006, European journal of clinical investigation.
[28] Yunliang Chen,et al. Matrix contraction by dermal fibroblasts requires transforming growth factor-beta/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic disease. , 2005, The American journal of pathology.
[29] D. Sorescu,et al. NAD(P)H Oxidase 4 Mediates Transforming Growth Factor-β1–Induced Differentiation of Cardiac Fibroblasts Into Myofibroblasts , 2005, Circulation research.
[30] S. Svegliati,et al. Platelet-derived Growth Factor and Reactive Oxygen Species (ROS) Regulate Ras Protein Levels in Primary Human Fibroblasts via ERK1/2 , 2005, Journal of Biological Chemistry.
[31] K. Kotoh,et al. Epigallocatechin-3-gallate, a polyphenol component of green tea, suppresses both collagen production and collagenase activity in hepatic stellate cells. , 2005, International journal of molecular medicine.
[32] E. Rosato,et al. Significant Changes of Peripheral Perfusion and Plasma Adrenomedullin Levels in N-Acetylcysteine Long Term Treatment of Patients with Sclerodermic Raynaud's Phenomenon , 2005, International journal of immunopathology and pharmacology.
[33] D. Alberts,et al. Effects of Dosing Condition on the Oral Bioavailability of Green Tea Catechins after Single-Dose Administration of Polyphenon E in Healthy Individuals , 2005, Clinical Cancer Research.
[34] J. Cracowski,et al. Effects of short-term treatment with vitamin E in systemic sclerosis: a double blind, randomized, controlled clinical trial of efficacy based on urinary isoprostane measurement. , 2005, Free radical biology & medicine.
[35] S. Hattori,et al. Epigallocatechin-3-O-gallate Inhibits Fibroblast Contraction of Floating Collagen Gel: Interaction between Epigallocatechin-3-O-gallate and Platelet Derived Growth Factor , 2004, Bioscience, biotechnology, and biochemistry.
[36] T. Ueno,et al. Green tea polyphenol epigallocatechin-3-gallate inhibits platelet-derived growth factor-induced proliferation of human hepatic stellate cell line LI90. , 2004, Journal of hepatology.
[37] Giulio Gabbiani,et al. Mechanisms of force generation and transmission by myofibroblasts. , 2003, Current opinion in biotechnology.
[38] Anping Chen,et al. The Antioxidant (–)-Epigallocatechin-3-gallate Inhibits Rat Hepatic Stellate Cell Proliferation in Vitro by Blocking the Tyrosine Phosphorylation and Reducing the Gene Expression of Platelet-derived Growth Factor-β Receptor* , 2003, Journal of Biological Chemistry.
[39] J. Lekakis,et al. Ascorbic acid does not improve endothelium-dependent flow-mediated dilatation of the brachial artery in patients with Raynaud's phenomenon secondary to systemic sclerosis. , 2003, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.
[40] Jianye Xu,et al. The antioxidant (-)-epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression. , 2002, The Biochemical journal.
[41] A. Gabrielli,et al. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. , 2001, Arthritis and rheumatism.
[42] A. Gabrielli,et al. Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a pilot study. , 2001, The Journal of rheumatology.
[43] H. Mukhtar,et al. Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress. , 2001, Carcinogenesis.
[44] A. Herrick,et al. The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis. , 2001, Clinical and experimental rheumatology.
[45] K. Miura,et al. Nerve Growth Factor-induced Neuronal Differentiation Requires Generation of Rac1-regulated Reactive Oxygen Species* , 2000, The Journal of Biological Chemistry.
[46] M. Jayson,et al. Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skin , 1999, The Journal of pathology.
[47] C. Rice-Evans,et al. Implications of the mechanisms of action of tea polyphenols as antioxidants in vitro for chemoprevention in humans. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[48] Y. Yun,et al. Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172). , 1999, Molecular biology of the cell.
[49] C. Denton,et al. Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon. , 1999, Rheumatology.
[50] J. Morrow,et al. Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. , 1996, Arthritis and rheumatism.
[51] C. Black,et al. Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis. , 1995, Arthritis and rheumatism.
[52] T. Cornwell,et al. Demonstration of a direct role for myosin light chain kinase in fibroblast‐populated collagen lattice contraction , 1991, Journal of cellular physiology.